US Patent 8404234 Fixed dosing of HER antibodies
Patent 8404234 was granted and assigned to Genentech on March, 2013 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 8404234 Fixed dosing of HER antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
